Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
- Sales down 10 per cent on reported basis - EPS falls 20 per cent - US weakness offsets growth elsewhere - Company changes guidance language The strength of sterling had a big impact on results at GlaxoSmithKline (GSK) in the first quarter, while sales fell short of analysts' expectations due to w
Read more
LONDON (Alliance News) - US equities are set to open marginally lower Wednesday, as investors digest the latest tranche of quarterly trading statements released after the Wall Street close on Tuesday, and ahead of some important US macroeconomic data and the latest Federal Open Market Committee p
Read more
GLAXOSMITHKLINE CEO SAYS NOT SURE A SINGLE NARRATIVE AROUND SECTOR M&A GLAXOSMITHKLINE CEO SAYS NO UPDATE ON CHINA INVESTIGATION GLAXOSMITHKLINE CEO SAYS U.S. ADVAIR SHARE FELL IN EARLY JANUARY BUT HAS SINCE STABILISED GLAXOSMITHKLINE CEO SAYS UK HAS "TERRIFIC" SCIENCE BASE AND GREAT SUPPORT FOR
Read more- Markets cautious ahead of FOMC outcome - Eurozone inflation picks up but misses consensus - Heritage Oil jumps on takeover offer - Shell and Tullow lead markets higher techMARK 2,775.59 -0.56% FTSE 100 6,776.83 +0.10% FTSE 250 15,813.39 -0.52% UK stocks were trading slightly higher on Wednesday
Read moreLONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite
Read more(Repeats to attach to Reuters alerts) LONDON, April 30 (Reuters) - GlaxoSmithKline posted a 10 percent fall in quarterly sales on Wednesday, highlighting some of the industry pressures behind last week's decision to trade more than $20 billion of assets with Swiss rival Novartis . Rep
Read moreLONDON, April 30 (Reuters) - GlaxoSmithKline posted a 10 percent fall in quarterly sales on Wednesday, highlighting some of the industry pressures behind last week's decision to trade more than $20 billion of assets with Swiss rival Novartis . Reported sales in the first quarter, which were
Read moreBy Kylie MacLellan and Ben Hirschler LONDON, April 30 (Reuters) - British lawmakers intend to investigate U.S. drugmaker Pfizer's planned $100 billion takeover of British rival AstraZeneca in a bid to ensure scientific research and jobs are protected. Members of the parliamentary busi
Read moreLAGOS, April 30 (Reuters) - GSK's Nigerian unit on Wednesday posted a first-quarter pretax profit of 892.13 million naira ($5.56 million), up 3.06 percent from 864.83 million a year earlier. Revenue rose to 7.80 billion naira from 6.92 billion, the pharmaceutical and healthcare company sai
Read moreLONDON (Alliance News) - UK stocks trade mixed Wednesday, as investors await a raft of releases from the US and after the preliminary reading of eurozone consumer price inflation accelerated from a more than four-year low, but still missed forecasts. By mid-morning, the FTSE 100 is marginal
Read more(An item published at 0745 BST misstated the time GlaxoSmithKline is due to release its first-quarter results. The correct time follows.) Pharmaceutical giant GlaxoSmithKline is due to publish its first quarter results at 1100 GMT. By James Kemp; jameskemp@alliancenews.com; @jamespkem
Read moreLONDON (Alliance News) - UK equities are set to open flat to slightly lower Wednesday, following some strong gains posted on Tuesday, as investors take their positions ahead of important macro economic releases from Europe and the US. Meanwhile, market participants in London face another da
Read moreThe upcoming session will again witness the release of a raft of corporate results, with many outfits set to go ex-dividend. Interim statements are due from several 'heavy hitters', including Barclays, Tullow Oil, Standard Life, British American Tobacco and Next. GlaxoSmithKline (GSK) and Royal
Read moreLONDON (Alliance News) - The FTSE 100 closed higher for the second day in a row Tuesday, ending the day at its highest closing level since March 6, buoyed in part by a strong performance by oil major BP and drugs company Shire.
Meanwhile, it was a volatile day for the pound. Sterlin
* Initial 30 pct cash component too low for AZ investors * Pfizer may give more cash but limited by UK domicile move * "White knights" thin on ground, Amgen said not interested By Ben Hirschler and Simon Jessop LONDON, April 29 (Reuters) - U.S. drugmaker Pfizer will need
Read more
Last checked at